The Allstate Corporation (ALL) Investor Update summary
Event summary combining transcript, slides, and related documents.
Investor Update summary
2 Feb, 2026Transaction overview
Agreement reached to sell the Employer Voluntary Benefits business to StanCorp Financial/The Standard for $2.0 billion in cash, representing a 20.6x earnings multiple over the last 12 months, subject to closing adjustments and approvals.
The sale is part of a broader strategy to combine Health and Benefits businesses with partners to unlock growth and synergies.
The transaction is expected to close in early to the first half of 2025, pending regulatory approvals from Florida, Oregon, and Hart-Scott-Rodino.
Allstate will provide transition services for up to two years and its exclusive agents will offer The Standard's products for five years post-sale.
Allstate will host a conference call and webcast to discuss the transaction, with J.P. Morgan and Ardea Partners advising Allstate and Citi advising The Standard.
Financial impact
The transaction will generate a financial book gain of about $600 million and increase available capital by $1.6 billion, about 8% above June 30, 2024.
The sale price nets to $1.7 billion after taxes, with a $600 million gain including goodwill allocation.
Revenues, investments, and adjusted net income will decrease by 2%-3% after the sale.
Adjusted net income return on equity will decrease by about 100 basis points due to lower income and higher equity.
Assets and liabilities will be reduced by $2.9 billion and $2.1 billion, respectively, upon reclassification as Held for Sale starting Q3 2024.
Business segment details and performance
Health & Benefits segment contributed 4% of 2023 revenues, with EVB accounting for 43% of segment revenue and 40% of adjusted net income.
Employer Voluntary Benefits business served over 3.5 million customers, with $535 million in revenue and $45 million in adjusted net income for H1 2024.
EVB serves 3.6 million policyholders through 4,000+ agents, offering life, accident, critical illness, and hospital indemnity products.
Statutory capital and surplus for the business stood at $255 million as of H1 2024.
Allstate retains the economics of the business until closing.
Latest events from The Allstate Corporation
- 2025 saw robust growth, cost savings, tech-driven expansion, and improved affordability.ALL
47th Annual Raymond James Institutional Investor Conference2 Mar 2026 - Strong premium reductions, record net income, and improved margins fueled higher shareholder returns.ALL
Q4 20255 Feb 2026 - Q2 2024 net income rebounded to $301M as premiums, margins, and investment income improved.ALL
Q2 20242 Feb 2026 - Growth driven by innovation, telematics, and disciplined expansion of protection services.ALL
The 44th Annual William Blair Growth Stock Conference31 Jan 2026 - Q3 net income hit $1.2B on 14.7% revenue growth, with a $2B business sale announced.ALL
Q3 202417 Jan 2026 - Growth accelerates with innovation, efficiency, and expanded protection driving results.ALL
Goldman Sachs 2024 U.S. Financial Services Conference11 Jan 2026 - Double-digit revenue growth, strong profitability, and strategic divestitures marked 2024.ALL
Q4 20249 Jan 2026 - Strong 2024 results, innovation, and capital returns fueled growth and market share gains.ALL
Raymond James & Associates’ 46th Annual Institutional Investors Conference 20257 Jan 2026 - Growth initiatives, tech innovation, and disciplined capital use drive market share and profitability.ALL
Goldman Sachs U.S. Financial Services Conference10 Dec 2025